Literature DB >> 35660072

Clinicopathologic features and proposed grossing protocol of orchiectomy specimens performed for gender affirmation surgery.

Kristine M Cornejo1, Esther Oliva2, Rory Crotty2, Peter M Sadow2, Kyle Devins2, Anton Wintner3, Chin-Lee Wu2.   

Abstract

Gender affirmation surgery performed for gender dysphoria is increasing to instigate changes more closely approximating gender identity. We investigated the clinicopathologic features of gender-affirming orchiectomies performed at our institution and devised a grossing protocol for these increasingly encountered specimens. We obtained 45 orchiectomies from 23 patients and reviewed clinicopathologic features. The number of sections per case was noted and reviewed to devise an optimal grossing protocol to assess pathologic findings. Twenty-three patients had bilateral orchiectomy with 1 unilateral. The average patient age was 39.4 years (range, 21-71 years); all received hormones for a mean of 66.1 months (range, 12-348 months). The average number of slides per orchiectomy was 8 slides (range, 1-11). Aspermatogenesis occurred in 32 (71%), hypospermatogenesis in 8 (18%), and normal spermatogenesis in 5 (11%) testes. Twenty-five (56%) exhibited scattered cells with nuclear cytomegaly, concerning for germ cell neoplasia in situ (GCNIS), but OCT4 negative. Six (13%) had multinucleated stromal cells. Leydig cells were markedly reduced/absent in 38 testes (85%). Epithelial hyperplasia was identified in 15 rete testes (33%) and 24 epididymes (53%), while 18 (40%) showed periepididymal muscular hyperplasia. All findings were identified in the initial 2 slides including rete testis/epididymis, except for 3 cases, missing only focal tubular sclerosis. Despite all received treatment, only a subset showed changes of exogenous hormone therapy. The presence of nuclear cytomegaly can mimic GCNIS and may be a potential pitfall. Two sections to include rete testis/epididymis and a third of cord margin are sufficient to identify the relevant pathology and germ cell tumors overall are uncommon in orchiectomies performed for gender affirmation.
Copyright © 2022. Published by Elsevier Inc.

Entities:  

Keywords:  Gender affirmation; Grossing; Orchiectomy; Transexual; Transgender

Mesh:

Substances:

Year:  2022        PMID: 35660072      PMCID: PMC9489654          DOI: 10.1016/j.humpath.2022.05.017

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.526


  28 in total

1.  Smooth muscle hyperplasia of the testicular adnexa clinically mimicking neoplasia: clinicopathologic study of sixteen cases.

Authors:  J H Barton; C J Davis; I A Sesterhenn; F K Mostofi
Journal:  Am J Surg Pathol       Date:  1999-08       Impact factor: 6.394

2.  Testicular Seminoma in a Transgender Woman: A Case Report.

Authors:  Elizabeth J Kvach; Jennifer S Hyer; John C Carey; Marci Bowers
Journal:  LGBT Health       Date:  2019-01       Impact factor: 4.151

3.  Effects of Feminizing Hormones on Sperm Production and Malignant Changes: Microscopic Examination of Post Orchiectomy Specimens in Transwomen.

Authors:  Marissa A Kent; Jared S Winoker; Aaron B Grotas
Journal:  Urology       Date:  2018-08-07       Impact factor: 2.649

4.  Vascular and inflammatory effects of estrogen and anti-androgen therapy in the testis and epididymis of male to female transgender adults.

Authors:  Cristina Peña Barreno; Pilar Gonzalez-Peramato; Manuel Nistal
Journal:  Reprod Toxicol       Date:  2020-05-11       Impact factor: 3.143

5.  The nature of atypical multinucleated stromal cells: a study of 37 cases from different sites.

Authors:  M A Pitt; I S Roberts; D A Agbamu; B P Eyden
Journal:  Histopathology       Date:  1993-08       Impact factor: 5.087

6.  The Amsterdam Cohort of Gender Dysphoria Study (1972-2015): Trends in Prevalence, Treatment, and Regrets.

Authors:  Chantal M Wiepjes; Nienke M Nota; Christel J M de Blok; Maartje Klaver; Annelou L C de Vries; S Annelijn Wensing-Kruger; Renate T de Jongh; Mark-Bram Bouman; Thomas D Steensma; Peggy Cohen-Kettenis; Louis J G Gooren; Baudewijntje P C Kreukels; Martin den Heijer
Journal:  J Sex Med       Date:  2018-02-17       Impact factor: 3.802

7.  Effects of Estrogen on Spermatogenesis in Transgender Women.

Authors:  Da David Jiang; Erica Swenson; Malachi Mason; Kevin R Turner; Daniel D Dugi; Jason C Hedges; Sarah L Hecht
Journal:  Urology       Date:  2019-07-13       Impact factor: 2.649

8.  Immunolocalization of oestrogen and progesterone receptors in prostatic hyperplasia and carcinoma.

Authors:  M Hiramatsu; I Maehara; S Orikasa; H Sasano
Journal:  Histopathology       Date:  1996-02       Impact factor: 5.087

9.  Spermatogenesis Abnormalities following Hormonal Therapy in Transwomen.

Authors:  Sirachai Jindarak; Kasama Nilprapha; Taywin Atikankul; Apichai Angspatt; Pornthep Pungrasmi; Seree Iamphongsai; Pasu Promniyom; Poonpissamai Suwajo; Gennaro Selvaggi; Preecha Tiewtranon
Journal:  Biomed Res Int       Date:  2018-04-02       Impact factor: 3.411

10.  Exogenous estrogen therapy, testicular cancer, and the male to female transgender population: a case report.

Authors:  Gursimran Chandhoke; Bobby Shayegan; Sebastien J Hotte
Journal:  J Med Case Rep       Date:  2018-12-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.